Energy Tropic Therapy in Modern Pediatrics
DOI:
https://doi.org/10.62480/tjms.2024.vol30.pp57-59Keywords:
mitochondrial diseases, secondary mitochondrial deficiency, energy-deficient diathesisAbstract
The article is devoted to the problems of using metabolic drugs that affect intracellular energy exchange processes. These drugs, which are proposed to be called energotropic, are becoming increasingly popular in modern medicine. The more urgent the task of determining the area of pathogenetic justification for their purpose becomes. The authors propose for discussion a range of indications for energotropic therapy. Various examples of the successful use of energotropic drugs in pediatrics are discussed
References
Belozerov E.S., Bulankov Yu.I., Mitin Yu.A. Immune system diseases. – Elista: APP “Dzhangar”, 2015. – T. 2.
Bobova L.P., Kuznetsov S.L., Saprykin V.P. Histophysiology of blood and hematopoietic organs and immunogenesis: textbook. allowance. – M.: Novaya Volna Publishing House LLC, 2013.
Borisov L.B. Medical microbiology, virology, immunology. – M.: Medical Information Agency LLC, 2011.
Burmester G.–R. Visual immunology / trans. from English – M.: BINOM, Knowledge Laboratory, 2017.
Galaktionov V.G. Immunology. – M.: Academy, 2014
Downloads
Published
Issue
Section
License
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
User Rights
Under the Creative Commons Attribution-NonCommercial 4.0 International (CC-BY-NC), the author (s) and users are free to share (copy, distribute and transmit the contribution).
Rights of Authors
Authors retain the following rights:
1. Copyright and other proprietary rights relating to the article, such as patent rights,
2. the right to use the substance of the article in future works, including lectures and books,
3. the right to reproduce the article for own purposes, provided the copies are not offered for sale,
4. the right to self-archive the article.
